V

Vaxcell Bio Therapeutics
KOSDAQ:323990

Watchlist Manager
Vaxcell Bio Therapeutics
KOSDAQ:323990
Watchlist
Price: 9 990 KRW -0.99% Market Closed
Market Cap: 232.4B KRW

Dividends

Vaxcell Bio Therapeutics
does not pay dividends

Shareholder Yield

Current shareholder yield for Vaxcell Bio Therapeutics is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Vaxcell Bio Therapeutics

1M 1M
-4%
6M 6M
+3%
1Y 1Y
-6%
3Y 3Y
-71%
5Y 5Y
-95%
10Y 10Y
-53%
Annual Price Range
9 990
52w Low
7 400
52w High
11 140
Price Metrics
Average Annual Return -43.16%
Standard Deviation of Annual Returns 32.1%
Max Drawdown -97%
Shares Statistics
Market Capitalization 231.5B KRW
Shares Outstanding 23 260 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Stock Splits

Vaxcell Bio Therapeutics's latest stock split occurred on Nov 10, 2023

The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.

Before the split, Vaxcell Bio Therapeutics traded at 23999.9908 per share. Afterward, the share price was about 21250.

The adjusted shares began trading on Nov 10, 2023. This was Vaxcell Bio Therapeutics's 3rd stock split, following the previous one in Sep 20, 2023.

Pre-Split Price
19 999.9924 23 999.9908
Post-Split Price
21 250
Before
After